New Study Supports Biotech Fears Over USPTO Changes

Law360, New York (July 13, 2006, 12:00 AM EDT) -- With the U.S. Patent and Trademark Office on the brink of implementing proposed changes to continuing application procedures, a new study contends that the amendments will have an adverse effect on the biotechnology and pharmaceutical areas.

Curious about the consequences of the proposed changes, a partner and a science advisor at Wilson Sonsini Goodrich & Rosati recently launched an investigation to determine whether the modifications would negatively affect the ability of biotech and pharmaceutical innovators to obtain valuable patent coverage, as the industries claim.

The change,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.